Serial Number | 90273167 |
Word Mark | PLATELETBIO |
Filing Date | Friday, October 23, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, June 5, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Pseudo Mark | PLATELET BIO |
Goods and Services | Research and development related to platelets, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, including, extracellular vesicles or exosomes; Research and development in the field of allogeneic cell therapy, platelet variants, drug delivery and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Biotechnology research; Research in the field of allogeneic cell therapy, platelet variants and pharmaceutical compositions comprising platelet variants; Pharmaceutical research and development; Medical research; Scientific research; Medical and scientific research in the field of allogeneic cell therapy, platelet variants, and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Research and development related to viral vectors and delivery of viral vectors |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 11, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Platelet BioGenesis, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Watertown, MA 02472 |
Event Date | Event Description |
Tuesday, June 6, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, June 5, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, June 5, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, October 17, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Monday, October 17, 2022 | FINAL REFUSAL E-MAILED |
Monday, October 17, 2022 | FINAL REFUSAL WRITTEN |
Thursday, April 14, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, April 14, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 13, 2022 | ASSIGNED TO LIE |
Thursday, April 7, 2022 | ASSIGNED TO LIE |
Wednesday, April 6, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Saturday, October 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, October 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, October 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, April 20, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 20, 2021 | NON-FINAL ACTION E-MAILED |
Tuesday, April 20, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, March 24, 2021 | ASSIGNED TO EXAMINER |
Friday, December 11, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 27, 2020 | NEW APPLICATION ENTERED |